
| ASSET | DATE | % RETURN |
|---|---|---|
Candel Therapeutics (CADL) | 3/22/2024 - 4/30/2024 | 373.15% |
Avalo Therapeutics (AVTX) | 3/22/2024 - 4/30/2024 | 266.6% |
Canopy Growth (CGC) | 3/22/2024 - 4/30/2024 | 216.6% |
Mesoblast (MESO) | 3/22/2024 - 4/30/2024 | 192.04% |
Aurora Cannabis (ACB) | 3/22/2024 - 4/30/2024 | 140.99% |
Red Cat (RCAT) | 3/22/2024 - 4/30/2024 | 116.25% |
Yatsen (YSG) | 3/22/2024 - 4/30/2024 | 105.16% |
Oruka Therapeutics (ORKA) | 3/22/2024 - 4/30/2024 | 96.07% |
POET Technologies (POET) | 3/22/2024 - 4/30/2024 | 88.97% |
Stoke Therapeutics (STOK) | 3/22/2024 - 4/30/2024 | 83.53% |
Ouster, Inc Common Stock (OUST) | 3/22/2024 - 4/30/2024 | 76.46% |
New Pacific Metals (NEWP) | 3/22/2024 - 4/30/2024 | 74.78% |
SNDL (SNDL) | 3/22/2024 - 4/30/2024 | 72.73% |
Lands’ End (LE) | 3/22/2024 - 4/30/2024 | 69.73% |
Cullinan Oncology LLC (CGEM) | 3/22/2024 - 4/30/2024 | 64.29% |
Benitec Biopharma Ltd ADR (BNTC) | 3/22/2024 - 4/30/2024 | 64.08% |
Nektar Therapeutics (NKTR) | 3/22/2024 - 4/30/2024 | 62.22% |
Village Farms International (VFF) | 3/22/2024 - 4/30/2024 | 56.12% |
ProKidney (PROK) | 3/22/2024 - 4/30/2024 | 48.56% |
Hycroft Mining (HYMC) | 3/22/2024 - 4/30/2024 | 43.91% |
Janux Therapeutics (JANX) | 3/22/2024 - 4/30/2024 | 42.5% |
Galectin Therapeutics (GALT) | 3/22/2024 - 4/30/2024 | 42.11% |
Paysign (PAYS) | 3/22/2024 - 4/30/2024 | 41.54% |
Babcock & Wilcox Enterprises (BWSN) | 3/22/2024 - 4/30/2024 | 37.28% |
Phibro Animal Health (PAHC) | 3/22/2024 - 4/30/2024 | 35.99% |